Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
5.21
Dollar change
+0.06
Percentage change
1.17
%
Index- P/E- EPS (ttm)-3.75 Insider Own2.66% Shs Outstand1.37M Perf Week-1.51%
Market Cap7.09M Forward P/E- EPS next Y-3.77 Insider Trans0.00% Shs Float1.32M Perf Month18.68%
Income-5.29M PEG- EPS next Q-1.15 Inst Own1.45% Short Float3.14% Perf Quarter8.77%
Sales0.01M P/S708.56 EPS this Y-24.47% Inst Trans-87.97% Short Ratio0.20 Perf Half Y-4.40%
Book/sh7.53 P/B0.69 EPS next Y19.44% ROA-35.36% Short Interest0.04M Perf Year0.37%
Cash/sh7.35 P/C0.71 EPS next 5Y- ROE-40.34% 52W Range3.93 - 13.30 Perf YTD13.02%
Dividend Est.- P/FCF- EPS past 5Y81.53% ROI-51.11% 52W High-60.83% Beta4.95
Dividend TTM- Quick Ratio27.64 Sales past 5Y-20.62% Gross Margin-990.93% 52W Low32.57% ATR (14)0.57
Dividend Ex-Date- Current Ratio27.65 EPS Y/Y TTM-103.90% Oper. Margin-62445.91% RSI (14)52.63 Volatility6.71% 14.19%
Employees4 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin-58739.71% Recom1.00 Target Price30.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q72.64% Payout- Rel Volume0.07 Prev Close5.15
Sales Surprise- EPS Surprise- Sales Q/Q-83.87% Earnings- Avg Volume208.21K Price5.21
SMA20-0.63% SMA5011.85% SMA2009.13% Trades Volume14,469 Change1.17%
Mar-27-24 09:00AM
Mar-07-24 11:04AM
09:15AM
Mar-06-24 07:00AM
Dec-20-23 09:35AM
08:00AM Loading…
Nov-15-23 08:00AM
Oct-10-23 08:00AM
Sep-19-23 08:00AM
Aug-24-23 10:45AM
Jul-13-23 09:00AM
Jun-28-23 08:00AM
Jun-12-23 08:01AM
08:00AM
Jun-09-23 12:30PM
May-31-23 08:00AM
08:30AM Loading…
May-22-23 08:30AM
May-18-23 08:00AM
May-14-23 08:13AM
Apr-12-23 08:00AM
Apr-04-23 08:00AM
Mar-23-23 08:00AM
Mar-21-23 08:00AM
Mar-07-23 08:00AM
Feb-14-23 08:00AM
Feb-08-23 08:00AM
Nov-03-22 07:30AM
Oct-20-22 08:00AM
Sep-26-22 08:00AM
Jul-28-22 07:30AM
Jun-15-22 08:30AM
08:40AM Loading…
Apr-29-22 08:40AM
Apr-20-22 08:30AM
Apr-12-22 08:30AM
Mar-31-22 08:30AM
Mar-23-22 08:30AM
Mar-10-22 08:30AM
Mar-08-22 08:30AM
Mar-02-22 08:30AM
Jan-20-22 07:15AM
Nov-09-21 04:45PM
Oct-12-21 08:15AM
Oct-01-21 08:15AM
Sep-16-21 07:45AM
Aug-09-21 04:43PM
Jul-20-21 07:45AM
Jun-22-21 07:45AM
Jun-17-21 07:00AM
Jun-09-21 08:18AM
May-24-21 07:45AM
May-20-21 08:45AM
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on immunology, urology, neurology and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. Its products include CaverStem, FemCelz, StemSpine and ImmCelz. The company was founded on December 3, 1998 and is headquartered in Phoenix, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Warbington TimothyPresident & CEOJun 28 '23Buy4.3620087212,209Jun 29 05:37 PM
Warbington TimothyPresident & CEOJun 27 '23Buy4.448003,55112,009Jun 29 05:37 PM